Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Barber

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Molecular Pharmaceutics|February 9, 2019
Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia PatientsZubida M Al-Majdoub, Hajar Al Feteisi, Brahim Achour, et al.
Journal of Proteome Research|October 16, 2013
Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transportersMatthew R Russell, Brahim Achour, Edward A Mckenzie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 13, 2021
Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver MetastasisAreti-Maria Vasilogianni, Brahim Achour, Daniel Scotcher, et al.
Journal of Proteomics|May 10, 2022
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver diseaseAreti-Maria Vasilogianni, Eman El-Khateeb, Zubida M Al-Majdoub, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Computational Studies on Selected Macrolides Active against <i>Escherichia coli</i> Combined with the NMR Study of Tylosin A in Deuterated ChloroformBiljana Arsic, Jill Barber, Ana Cikos, et al.
Journal of Proteomics|March 30, 2022
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteinsAreti-Maria Vasilogianni, Eman El-Khateeb, Brahim Achour, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2022
Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and TransportersJill Barber, Zubida M Al-Majdoub, Narciso Couto, et al.
Clinical Pharmacology and Therapeutics|May 15, 2025
Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease PatientsAnnika C Tillmann, Dorien J M Peters, Amin Rostami-Hodjegan, et al.
Clinical Pharmacology and Therapeutics|October 28, 2020
Quantification of Proteins Involved in Intestinal Epithelial Handling of XenobioticsZubida M Al-Majdoub, Narciso Couto, Brahim Achour, et al.
Molecular Pharmaceutics|April 24, 2026
Proteomics-Informed Physiologically Based Pharmacokinetic Modeling for Aldehyde Oxidase Substrates in Colorectal Cancer Liver MetastasisNihan Izat, Areti-Maria Vasilogianni, Zubida M Al-Majdoub, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Molecular Pharmaceutics|February 9, 2019
Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia PatientsZubida M Al-Majdoub, Hajar Al Feteisi, Brahim Achour, et al.
Journal of Proteome Research|October 16, 2013
Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transportersMatthew R Russell, Brahim Achour, Edward A Mckenzie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 13, 2021
Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver MetastasisAreti-Maria Vasilogianni, Brahim Achour, Daniel Scotcher, et al.
Journal of Proteomics|May 10, 2022
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver diseaseAreti-Maria Vasilogianni, Eman El-Khateeb, Zubida M Al-Majdoub, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Computational Studies on Selected Macrolides Active against <i>Escherichia coli</i> Combined with the NMR Study of Tylosin A in Deuterated ChloroformBiljana Arsic, Jill Barber, Ana Cikos, et al.
Journal of Proteomics|March 30, 2022
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteinsAreti-Maria Vasilogianni, Eman El-Khateeb, Brahim Achour, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2022
Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and TransportersJill Barber, Zubida M Al-Majdoub, Narciso Couto, et al.
Clinical Pharmacology and Therapeutics|May 15, 2025
Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease PatientsAnnika C Tillmann, Dorien J M Peters, Amin Rostami-Hodjegan, et al.
Clinical Pharmacology and Therapeutics|October 28, 2020
Quantification of Proteins Involved in Intestinal Epithelial Handling of XenobioticsZubida M Al-Majdoub, Narciso Couto, Brahim Achour, et al.
Molecular Pharmaceutics|April 24, 2026
Proteomics-Informed Physiologically Based Pharmacokinetic Modeling for Aldehyde Oxidase Substrates in Colorectal Cancer Liver MetastasisNihan Izat, Areti-Maria Vasilogianni, Zubida M Al-Majdoub, et al.
Pageof 8